GPR30
- $290.7 - $588
- Product name: GPR30
- CAS:
- MF:
- MW: 0
- EINECS:
- MDL Number:
- Synonyms:ANTI-GPER (C-TERM) antibody produced in rabbit;CEPR;CMKRL2;DRY12;GPER;GPR30;G-protein coupled estrogen receptor 1;Anti-GPER (C-terminal) antibody produced in rabbit
4 prices
Selected condition:
Brand
- Biorbyt Ltd
- Sigma-Aldrich
- Usbiological
Package
- 10μg
- 48Tests
- 100μL
- 400μl
- ManufacturerBiorbyt Ltd
- Product numberorb602123
- Product descriptionGPER
- Packaging10μg
- Price$290.7
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberSAB2700363
- Product descriptionAnti-GPER (C-terminal) antibody produced in rabbit affinity isolated antibody, buffered aqueous solution
- Packaging100μL
- Price$496
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberSAB1304967
- Product descriptionANTI-GPER (C-TERM) antibody produced in rabbit IgG fraction of antiserum, buffered aqueous solution
- Packaging400μl
- Price$427
- Updated2022-05-15
- Buy
- ManufacturerUsbiological
- Product number356063
- Product descriptionGper
- Packaging48Tests
- Price$588
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Biorbyt Ltd | orb602123 | GPER | 10μg | $290.7 | 2021-12-16 | Buy |
Sigma-Aldrich | SAB2700363 | Anti-GPER (C-terminal) antibody produced in rabbit affinity isolated antibody, buffered aqueous solution | 100μL | $496 | 2024-03-01 | Buy |
Sigma-Aldrich | SAB1304967 | ANTI-GPER (C-TERM) antibody produced in rabbit IgG fraction of antiserum, buffered aqueous solution | 400μl | $427 | 2022-05-15 | Buy |
Usbiological | 356063 | Gper | 48Tests | $588 | 2021-12-16 | Buy |
Properties
storage temp. :-20°C
form :buffered aqueous solution
form :buffered aqueous solution
Safety Information
Symbol(GHS): | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||
Precautionary statements: |
|